Key stats
Market capitalization
240.146MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.00USD
About Fusion Pharmaceuticals Inc
ISIN
CA36118A1003
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
fusionpharma.com
CEO
John Valliant
Headquarters
Hamilton
Employees
102
Founded
2014
Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant in 2014 and is headquartered in Hamilton, Canada.
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0